1.Lal DR., Clark I., Shalkow J., Downey RJ., Shorter NA., Klimstra DS, et al. Primary epithelial lung malignancies in the pediatric population. Pediatr Blood Cancer. 2005. 45:683–6.
Article
2.Hauso O., Gustafsson BI., Kidd M., Waldum HL., Drozdov I., Chan AKC, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer. 2008. 113:2655–64.
3.Wang LT., Wilkins EW Jr., Bode HH. Bronchial carcinoid tumors in pediatric patients. chest. 1993. 103:1426–8.
Article
4.Eyssartier E., Ang P., Bonnemaison E., Gibertini I., Diot P., Carpentier E, et al. Characteristics of Endobronchial Primitive Tumors in Children. Pediatric Pulmonol. 2014. 49:121–5.
Article
5.Skuladottir H., Hirsch FR., Hansen HH., Olsen JH. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer. 2002. 37:127–35.
Article
6.Divisi D., Crisci R. Carcinoid tumors of the lung and multimodal therapy. Thorac Cardiovasc Surg. 2005. 53:168–72.
Article
7.Fink G., Krelbaum T., Yellin A., Bendayan D., Saute M., Glazer M, et al. Pulmonary carcinoid: pre- sentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest. 2001. 119:1647–51.
8.Kulke MH., Mayer RJ. Carcinoid tumors. N Engl J Med. 1999. 340:858–68.
Article
9.Travis WB. The concept of pulmonary neuroendocrine tumors. Travis WB, Brambilla E, Muller-Hermeli HK, Harris CC, editors. editors.Pathology and genetics of tumours of lung, pleura, thymus, and heart. Lyon: IARC Press;2004. p. 19–20.
10.Steven RB. Glenna BW. Emphysema and Overinflation. Robert MK, Bonita FS, Joseph WS, Nina FS, Richard EB, editors. editors.Nelson Textbook of Pediatrics. 19th ed.Philadelphia: Elsevier saunders;2011. p. 1460–1461.